[go: up one dir, main page]

NO20010489D0 - Forhindring av migrenetilbakefall - Google Patents

Forhindring av migrenetilbakefall

Info

Publication number
NO20010489D0
NO20010489D0 NO20010489A NO20010489A NO20010489D0 NO 20010489 D0 NO20010489 D0 NO 20010489D0 NO 20010489 A NO20010489 A NO 20010489A NO 20010489 A NO20010489 A NO 20010489A NO 20010489 D0 NO20010489 D0 NO 20010489D0
Authority
NO
Norway
Prior art keywords
prevention
relapse
migraine
migraine relapse
Prior art date
Application number
NO20010489A
Other languages
English (en)
Other versions
NO20010489L (no
Inventor
Neville Colin Jackson
Stephen Uden
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20010489D0 publication Critical patent/NO20010489D0/no
Publication of NO20010489L publication Critical patent/NO20010489L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20010489A 1998-07-30 2001-01-29 Forhindring av migrenetilbakefall NO20010489L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9816556.6A GB9816556D0 (en) 1998-07-30 1998-07-30 Therapy
PCT/IB1999/001105 WO2000006161A1 (en) 1998-07-30 1999-06-14 Prevention of migraine recurrence

Publications (2)

Publication Number Publication Date
NO20010489D0 true NO20010489D0 (no) 2001-01-29
NO20010489L NO20010489L (no) 2001-03-26

Family

ID=10836395

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010489A NO20010489L (no) 1998-07-30 2001-01-29 Forhindring av migrenetilbakefall

Country Status (36)

Country Link
EP (3) EP1100499B1 (no)
JP (1) JP3824863B2 (no)
KR (2) KR100441732B1 (no)
CN (2) CN1155379C (no)
AP (1) AP1402A (no)
AT (1) ATE261304T1 (no)
AU (1) AU3952199A (no)
BG (1) BG65309B1 (no)
BR (1) BR9912588A (no)
CA (1) CA2338901C (no)
CZ (1) CZ2001357A3 (no)
DE (1) DE69915486T2 (no)
DK (1) DK1100499T3 (no)
EA (2) EA200201149A1 (no)
EE (1) EE04703B1 (no)
ES (1) ES2214027T3 (no)
GB (1) GB9816556D0 (no)
GE (2) GEP20043157B (no)
HK (1) HK1038198A1 (no)
HR (1) HRP20010079A2 (no)
HU (1) HUP0103424A3 (no)
ID (1) ID26996A (no)
IL (1) IL140169A0 (no)
IS (1) IS2253B (no)
NO (1) NO20010489L (no)
NZ (2) NZ508736A (no)
OA (1) OA11576A (no)
PL (1) PL194611B1 (no)
PT (1) PT1100499E (no)
SG (1) SG125910A1 (no)
SK (1) SK1182001A3 (no)
TR (1) TR200100314T2 (no)
TW (2) TWI248362B (no)
UA (1) UA76399C2 (no)
WO (1) WO2000006161A1 (no)
YU (2) YU6401A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
GB9915231D0 (en) 1999-06-29 1999-09-01 Pfizer Ltd Pharmaceutical complex
CN1176649C (zh) * 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
US7332183B2 (en) * 2002-12-26 2008-02-19 Pozen Inc. Multilayer dosage forms containing NSAIDs and triptans
EP1615635A1 (en) 2003-04-11 2006-01-18 Pfizer Limited Pharmaceutical combination comprising eletriptan and sodium bicarbonate
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
FR2926721B1 (fr) * 2008-01-30 2011-07-22 Philippe Perovitch Forme galenique pour l'adminsitration par voie trans-muqueuse de triptans
CA2765866C (en) 2008-06-20 2016-06-21 Alphapharm Pty Ltd Single phase pharmaceutical composition of a 5-ht1 inhibitor and an nsaid
EP2490669B1 (en) 2009-10-23 2017-01-11 Fortuderm Ltd. Triptans for the treatment of psoriasis
MY169068A (en) * 2012-04-18 2019-02-12 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
CN103385876B (zh) * 2012-05-08 2016-01-13 四川滇虹医药开发有限公司 一种夫罗曲坦的药物组合物及其制备方法
CN104523709A (zh) * 2014-12-22 2015-04-22 青岛正大海尔制药有限公司 一种含有琥珀酸夫罗曲坦的复方缓释制剂
US11975104B2 (en) 2016-07-11 2024-05-07 Contera Pharma A/S Pulsatile drug delivery system for treating morning akinesia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2575272B2 (ja) * 1990-10-15 1997-01-22 フアイザー・インコーポレイテツド インドール誘導体
EP0546593B1 (en) * 1991-10-30 1997-09-03 Glaxo Group Limited Multi-layered compositions containing histamine or serotonin antagonists
US5464633A (en) * 1994-05-24 1995-11-07 Jagotec Ag Pharmaceutical tablets releasing the active substance after a definite period of time
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5698571A (en) * 1994-10-05 1997-12-16 Eli Lilly And Company 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine
US5744482A (en) * 1994-10-05 1998-04-28 Eli Lilly And Company Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine
IL127955A0 (en) * 1996-07-11 1999-11-30 Farmarc Nederland Bv Pharmaceutical composition containing acid addition salt of basic drug
ID24528A (id) * 1997-07-03 2000-07-20 Pfizer Komposisi-komposisi obat farmasi yang mengandung eletriptan hemisulfat dan kafein
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape

Also Published As

Publication number Publication date
IL140169A0 (en) 2002-02-10
EP1466601A3 (en) 2005-04-13
EA200100089A1 (ru) 2001-08-27
JP2002521446A (ja) 2002-07-16
PT1100499E (pt) 2004-06-30
PL194611B1 (pl) 2007-06-29
BG65309B1 (bg) 2008-01-31
DE69915486T2 (de) 2005-03-03
HUP0103424A2 (hu) 2002-02-28
BG105277A (en) 2001-11-30
TW537893B (en) 2003-06-21
HK1038198A1 (en) 2002-03-08
EP1100499A1 (en) 2001-05-23
KR100441732B1 (ko) 2004-07-27
CN1522697A (zh) 2004-08-25
TWI248362B (en) 2006-02-01
CA2338901A1 (en) 2000-02-10
NZ508736A (en) 2003-09-26
HUP0103424A3 (en) 2003-05-28
KR20030078876A (ko) 2003-10-08
YU20303A (sh) 2006-08-17
AU3952199A (en) 2000-02-21
NO20010489L (no) 2001-03-26
JP3824863B2 (ja) 2006-09-20
EE200100061A (et) 2002-06-17
SG125910A1 (en) 2006-10-30
EP1435237A1 (en) 2004-07-07
TW200300674A (en) 2003-06-16
ID26996A (id) 2001-02-22
DE69915486D1 (de) 2004-04-15
AP2001002056A0 (en) 2001-03-31
ATE261304T1 (de) 2004-03-15
IS5771A (is) 2000-12-15
CN1309560A (zh) 2001-08-22
DK1100499T3 (da) 2004-06-14
PL345803A1 (en) 2002-01-02
WO2000006161A1 (en) 2000-02-10
OA11576A (en) 2004-07-01
GEP20043157B (en) 2004-01-26
ES2214027T3 (es) 2004-09-01
UA76399C2 (en) 2006-08-15
BR9912588A (pt) 2001-05-02
EA004036B1 (ru) 2003-12-25
TR200100314T2 (tr) 2001-06-21
CA2338901C (en) 2008-02-19
EP1100499B1 (en) 2004-03-10
IS2253B (is) 2007-06-15
HRP20010079A2 (en) 2002-02-28
YU6401A (sh) 2004-03-12
GEP20063719B (en) 2006-01-10
KR20010079582A (ko) 2001-08-22
CN1155379C (zh) 2004-06-30
NZ527625A (en) 2005-01-28
EE04703B1 (et) 2006-10-16
EP1466601A2 (en) 2004-10-13
CZ2001357A3 (cs) 2001-10-17
SK1182001A3 (en) 2001-10-08
EA200201149A1 (ru) 2003-02-27
AP1402A (en) 2005-04-29
GB9816556D0 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
IS5574A (is) Útskiptir Xa-þáttar oxóasaheterósýklýl-tálmar
NO20003486L (no) Belegg av polymerer
PT1161420E (pt) Fungicidas de pirazol-carboxanilidas
ID27092A (id) Pembuatan ftalat anhidrida
NO20010899D0 (no) Forbedring av ugunstige apomorfin-effekter
IT1295008B1 (it) Combinazione di stabilizzanti
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
NO994790L (no) Estimering av permabilitet
NO20010489D0 (no) Forhindring av migrenetilbakefall
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO991115D0 (no) Belegging av mineralholdige st°peartikler
NO20006262D0 (no) Fôring av rör
ATA146797A (de) Schallschutzwand
NO20012276L (no) Identifisering av SENV-genotyper
FI19991831L (fi) Eristysmateriaalien pinnoite
NO20021260L (no) Estimering av amplityde-spektra
NO20003529D0 (no) Behandling av dyskinesi
DE59901997D1 (de) Thermochrome beschichtung
NO980820L (no) Dusjhode
FI980146A0 (fi) Foerfarande foer roentgenavbildning av huvud- och halsomraodet
NO20011268D0 (no) Forbindelse til behandling av depresjon
FI982552A0 (fi) Stabilointimenetelmä
SE9801284D0 (sv) Installation av spishäll
NO994020L (no) Kansellering av interferens
FI980470A0 (fi) Anvaendning av kyl- och bakvattnen i vattenhydraulikapplikationer i pappers- och kartongmaskiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application